In CP-induced AKI mice and cell models, protein levels of SIRT3 were found to be increased significantly with liquiritigenin treatment, indicating the regulatory ability of liquiritigenin in mitochondrial biogenesis through the NRF2/SIRT3 pathway against CP-induced AKI. The gene discussed is NFE2L2; the disease is acute kidney injury.